Enhanced control of dangerous biological agents and toxins
Regulatory control of certain biological agents and toxins
List of biological agents and toxins
In general
Criteria
In determining whether to include an agent or toxin on the list under subparagraph (A), the Secretary shall—
consider—
the effect on human health of exposure to the agent or toxin;
the degree of contagiousness of the agent or toxin and the methods by which the agent or toxin is transferred to humans;
the availability and effectiveness of pharmacotherapies and immunizations to treat and prevent any illness resulting from infection by the agent or toxin; and
any other criteria, including the needs of children and other vulnerable populations, that the Secretary considers appropriate; and
consult with appropriate Federal departments and agencies and with scientific experts representing appropriate professional groups, including groups with pediatric expertise.
Biennial review
Regulation of transfers of listed agents and toxins
The Secretary shall by regulation provide for—
the establishment and enforcement of safety procedures for the transfer of listed agents and toxins, including measures to ensure—
proper training and appropriate skills to handle such agents and toxins; and
proper laboratory facilities to contain and dispose of such agents and toxins;
the establishment and enforcement of safeguard and security measures to prevent access to such agents and toxins for use in domestic or international terrorism or for any other criminal purpose;
the establishment of procedures to protect the public safety in the event of a transfer or potential transfer of such an agent or toxin in violation of the safety procedures established under paragraph (1) or the safeguard and security measures established under paragraph (2); and
appropriate availability of biological agents and toxins for research, education, and other legitimate purposes.
Possession and use of listed agents and toxins
Registration; identification; database
Registration
Identification; database
Safeguard and security requirements for registered persons
In general
Limiting access to listed agents and toxins
Requirements under paragraph (1) shall include provisions to ensure that registered persons—
provide access to listed agents and toxins to only those individuals whom the registered person involved determines have a legitimate need to handle or use such agents and toxins;
submit the names and other identifying information for such individuals to the Secretary and the Attorney General, promptly after first determining that the individuals need access under subparagraph (A), and periodically thereafter while the individuals have such access, not less frequently than once every five years;
deny access to such agents and toxins by individuals whom the Attorney General has identified as restricted persons; and
limit or deny access to such agents and toxins by individuals whom the Attorney General has identified as within any category under paragraph (3)(B)(ii), if limiting or denying such access by the individuals involved is determined appropriate by the Secretary, in consultation with the Attorney General.
Submitted names; use of databases by attorney general
In general
Certain individuals
For purposes of subparagraph (A), the categories specified in this subparagraph regarding an individual are that—
the individual is a restricted person; or
the individual is reasonably suspected by any Federal law enforcement or intelligence agency of—
committing a crime set forth in section 2332b(g)(5) of title 18;
knowing involvement with an organization that engages in domestic or international terrorism (as defined in section 2331 of such title 18) or with any other organization that engages in intentional crimes of violence; or
being an agent of a foreign power (as defined in section 1801 of title 50).
Notification by Attorney General regarding submitted names
Notifications by Secretary
Expedited review
Regulations under subsections (b) and (c) of this section shall provide for a procedure through which, upon request to the Secretary by a registered person who submits names and other identifying information under paragraph (2)(B) and who demonstrates good cause, the Secretary may, as determined appropriate by the Secretary—
request the Attorney General to expedite the process of identification under paragraph (3)(A) and notification of the Secretary under paragraph (3)(C); and
expedite the notification of the registered person by the Secretary under paragraph (4).
Process regarding persons seeking to register
Individuals
Other persons
Review
Administrative review
In general
Regulations under subsections (b) and (c) of this section shall provide for an opportunity for a review by the Secretary—
when requested by the individual involved, of a determination under paragraph (2) to deny the individual access to listed agents and toxins; and
when requested by the person involved, of a determination under paragraph (6) to deny or revoke registration for such person.
Ex parte review
Final agency action
Certain procedures
Submission of ex parte materials in judicial proceedings
Disclosure of information
Notifications regarding theft or loss of agents
Technical assistance for registered persons
Inspections
Exemptions
Clinical or diagnostic laboratories
Regulations under subsections (b) and (c) of this section shall exempt clinical or diagnostic laboratories and other persons who possess, use, or transfer listed agents or toxins that are contained in specimens presented for diagnosis, verification, or proficiency testing, provided that—
the identification of such agents or toxins is reported to the Secretary, and when required under Federal, State, or local law, to other appropriate authorities; and
such agents or toxins are transferred or destroyed in a manner set forth by the Secretary by regulation.
Products
In general
Relevant laws
For purposes of subparagraph (A), the Acts specified in this subparagraph are the following:
The Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.].
The Act commonly known as the Virus-Serum-Toxin Act (the eighth paragraph under the heading “Bureau of Animal Industry” in the Act of
The Federal Insecticide, Fungicide, and Rodenticide Act [7 U.S.C. 136 et seq.].
Investigational use
In general
Certain processes
Regulations under subsections (b) and (c) of this section shall set forth the procedures for applying for an exemption under clause (i). In the case of investigational products authorized under any of the Acts specified in subparagraph (B), the Secretary shall make a determination regarding a request for an exemption not later than 14 days after the first date on which both of the following conditions have been met by the person requesting the exemption:
The person has submitted to the Secretary an application for the exemption meeting the requirements established by the Secretary.
The person has notified the Secretary that the investigation has been authorized under such an Act.
Public health emergencies
Agricultural emergencies
Disclosure of information
Nondisclosure of certain information
No Federal agency specified in paragraph (2) shall disclose under section 552 of title 5 any of the following:
Any registration or transfer documentation submitted under subsections (b) and (c) of this section for the possession, use, or transfer of a listed agent or toxin; or information derived therefrom to the extent that it identifies the listed agent or toxin possessed, used, or transferred by a specific registered person or discloses the identity or location of a specific registered person.
The national database developed pursuant to subsection (d) of this section, or any other compilation of the registration or transfer information submitted under subsections (b) and (c) of this section to the extent that such compilation discloses site-specific registration or transfer information.
Any portion of a record that discloses the site-specific or transfer-specific safeguard and security measures used by a registered person to prevent unauthorized access to listed agents and toxins.
Any notification of a release of a listed agent or toxin submitted under subsections (b) and (c) of this section, or any notification of theft or loss submitted under such subsections.
Any portion of an evaluation or report of an inspection of a specific registered person conducted under subsection (f) of this section that identifies the listed agent or toxin possessed by a specific registered person or that discloses the identity or location of a specific registered person if the agency determines that public disclosure of the information would endanger public health or safety.
Covered agencies
For purposes of paragraph (1) only, the Federal agencies specified in this paragraph are the following:
The Department of Health and Human Services, the Department of Justice, the Department of Agriculture, and the Department of Transportation.
Any Federal agency to which information specified in paragraph (1) is transferred by any agency specified in subparagraph (A) of this paragraph.
Any Federal agency that is a registered person, or has a sub-agency component that is a registered person.
Any Federal agency that awards grants or enters into contracts or cooperative agreements involving listed agents and toxins to or with a registered person, and to which information specified in paragraph (1) is transferred by any such registered person.
Other exemptions
Rule of construction
Except as specifically provided in paragraph (1), this subsection may not be construed as altering the authority of any Federal agency to withhold under section 552 of title 5, or the obligation of any Federal agency to disclose under section 552 of title 5, any information, including information relating to—
listed agents and toxins, or individuals seeking access to such agents and toxins;
registered persons, or persons seeking to register their possession, use, or transfer of such agents and toxins;
general safeguard and security policies and requirements under regulations under subsections (b) and (c) of this section; or
summary or statistical information concerning registrations, registrants, denials or revocations of registrations, listed agents and toxins, inspection evaluations and reports, or individuals seeking access to such agents and toxins.
Disclosures to Congress; other disclosures
This subsection may not be construed as providing any authority—
to withhold information from the Congress or any committee or subcommittee thereof; or
to withhold information from any person under any other Federal law or treaty.
Civil money penalty
In general
Applicability of certain provisions
Notification in event of release
Reports
Definitions
For purposes of this section:
The terms “biological agent” and “toxin” have the meanings given such terms in section 178 of title 18.
The term “listed agents and toxins” means biological agents and toxins listed pursuant to subsection (a)(1) of this section.
The term “listed agents or toxins” means biological agents or toxins listed pursuant to subsection (a)(1) of this section.
The term “overlap agents and toxins” means biological agents and toxins that—
are listed pursuant to subsection (a)(1) of this section; and
are listed pursuant to section 8401(a)(1) of title 7.
The term “overlap agent or toxin” means a biological agent or toxin that—
is listed pursuant to subsection (a)(1) of this section; and
is listed pursuant to section 8401(a)(1) of title 7.
The term “person” includes Federal, State, and local governmental entities.
The term “registered person” means a person registered under regulations under subsection (b) or (c) of this section.
The term “restricted person” has the meaning given such term in section 175b of title 18.
Authorization of appropriations
Source
(July 1, 1944, ch. 373, title III, § 351A, as added Pub. L. 107–188, title II, § 201(a),Notes
References in Text
Amendments
Effective Date of 2002 Amendment
Effective Date
Regulations
National Science Advisory Board for Biosecurity
a core curriculum and training requirements for workers in maximum containment biological laboratories; and
periodic evaluations of maximum containment biological laboratory capacity nationwide and assessments of the future need for increased laboratory capacity.”
Report to Congress
Implementation by Department of Health and Human Services
Date Certain for Notice of Possession.—
Not later than 90 days after the date of the enactment of this Act [
Date Certain for Promulgation; Effective Date Regarding Criminal and Civil Penalties.—
Not later than 180 days after the date of the enactment of this Act [
section 175b(c) of title 18, United States Code (relating to criminal penalties), as added by section 231(a)(5) of this Act; and
section 351A(i) of the Public Health Service Act [42 U.S.C. 262a(i)] (relating to civil penalties).
Transitional Provision Regarding Current Research and Education.—
The interim final rule under subsection (b) shall include time frames for the applicability of the rule that minimize disruption of research or educational projects that involve biological agents and toxins listed pursuant to section 351A(a)(1) of the Public Health Service Act [42 U.S.C. 262a(a)(1)] and that were underway as of the effective date of such rule.”